Axogen, Inc. — Investor Relations & Filings
Filings indexed
1,140
across all filing types
Latest filing
2026-04-29
Annual Report
Country
US
United States of America
Listing
US
AXGN
Axogen, Inc. is a regenerative medicine company focused on developing and commercializing surgical solutions for peripheral nerve repair. The company provides technologies designed to restore sensation and functionality to individuals with damaged peripheral nerves. Its portfolio is centered on products that facilitate nerve regeneration and repair, such as the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve gaps. Axogen's solutions are utilized by surgeons to treat patients with nerve injuries resulting from trauma or other medical conditions, aiming to improve their quality of life by restoring function and reducing pain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | |
| 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | |
| 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38812505 | ARS - Axogen, Inc. (0000805928) (Filer) | 2026-04-29 | English | ||
| 38156020 | 10-Q - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 37961677 | 8-K - Axogen, Inc. (0000805928) (Filer) | 2026-04-28 | English | ||
| 32881519 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881520 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881521 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-03-03 | English | ||
| 32881522 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881523 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-27 | English | ||
| 32881524 | 4 - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881526 | 10-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 32881525 | 8-K - AXOGEN, INC. (0000805928) (Filer) | 2026-02-24 | English | ||
| 18776430 | 8-K Filing | 2026-01-23 | English | ||
| 18776423 | 424B5 Filing | 2026-01-23 | English | ||
| 18776405 | 424B5 Filing | 2026-01-21 | English | ||
| 18776372 | S-3ASR Filing | 2026-01-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIMMUNE CORPORATION
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
Axogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32414/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32414 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32414 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32414 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32414}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axogen, Inc. (id: 32414)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.